Jane Street
VERA icon

Jane Street’s Vera Therapeutics VERA Stock Holding History

Jane Street’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Sell
39,300
-19,700
-33% -$734K ﹤0.01% 5492
2026
Q1 		$2.37M Buy
59,000
+48,700
+473% +$2.1M ﹤0.01% 4760
2025
Q4 		$522K Buy
+10,300
New +$366K ﹤0.01% 7587
2025
Q3 		– Sell
-74,600
Closed -$1.76M – 11852
2025
Q2 		$1.76M Buy
+74,600
New +$1.68M ﹤0.01% 4625
2025
Q1 		– Sell
-21,900
Closed -$926K – 10688
2024
Q4 		$926K Sell
21,900
-11,300
-34% -$500K ﹤0.01% 5540
2024
Q3 		$1.47M Buy
+33,200
New +$1.26M ﹤0.01% 5092
2024
Q2 		– Sell
-12,800
Closed -$552K – 10241
2024
Q1 		$552K Buy
+12,800
New +$456K ﹤0.01% 6483
2023
Q3 		– Sell
-24,100
Closed -$387K – 9456
2023
Q2 		$387K Buy
+24,100
New +$218K ﹤0.01% 6711

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jane Street's VERA Position: Q2 2026 in Review

Jane Street sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 21,150 shares — an estimated $788K sold.

Jane Street first reported a position in VERA in Q4 2021 and held it in 10 quarters. The position peaked at $5.35M in Q2 2024. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Jane Street reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 21,150 Vera Therapeutics shares in Q2 2026, an estimated $788K.
  • Jane Street first reported a position in Vera Therapeutics in Q4 2021 and held it in 10 quarters.
  • Jane Street's Vera Therapeutics position peaked at $5.35M in Q2 2024.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.